InsiderTrades.com logo
Biden replacement revealed?
From Paradigm Press   |   Ad
A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.
See his shocking evidence in this new report

NEUE Insider Trading

Insider Ownership Percentage: 64.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $230,365.29

NeueHealth Insider Trading History Chart

This chart shows the insider buying and selling history at NeueHealth by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NeueHealth Share Price & Price History

Current Price: $6.07
Price Change: ▼ Price Decrease of -0.08 (-1.30%)
As of 05/2/2024 01:00 AM ET

This chart shows the closing price history over time for NEUE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Biden to Launch “FedNOW” [Move Your Money Now]
From Priority Gold   |   Ad
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...
Get your free information kit NOW, before it's too late.

NeueHealth Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/18/2024George Lawrence Mikan IIICEOSell4,990$7.27$36,277.3064,832View SEC Filing Icon  
3/18/2024Jay MatushakCFOSell1,083$7.27$7,873.418,643View SEC Filing Icon  
3/18/2024Jeffery Michael CraigInsiderSell260$7.27$1,890.203,426View SEC Filing Icon  
3/18/2024Jeffrey J SchermanCAOSell568$7.27$4,129.363,440View SEC Filing Icon  
3/18/2024Tomas OrozcoEVPSell822$7.27$5,975.945,092View SEC Filing Icon  
3/15/2024George Lawrence Mikan IIICEOSell3,442$7.10$24,438.2069,822View SEC Filing Icon  
3/15/2024Jay MatushakCFOSell248$7.10$1,760.809,726View SEC Filing Icon  
3/15/2024Jeffery Michael CraigInsiderSell151$7.10$1,072.103,686View SEC Filing Icon  
3/15/2024Jeffrey J SchermanCAOSell98$7.10$695.804,008View SEC Filing Icon  
3/15/2024Tomas OrozcoEVPSell79$7.10$560.905,914View SEC Filing Icon  
3/13/2024George Lawrence Mikan IIICEOSell3,463$7.30$25,279.9075,662View SEC Filing Icon  
3/13/2024Jay MatushakCFOSell251$7.30$1,832.3010,147View SEC Filing Icon  
3/13/2024Jeffery Michael CraigInsiderSell152$7.30$1,109.603,942View SEC Filing Icon  
3/13/2024Jeffrey J SchermanCAOSell99$7.30$722.704,174View SEC Filing Icon  
3/13/2024Tomas OrozcoEVPSell78$7.30$569.406,047View SEC Filing Icon  
3/11/2024George Lawrence Mikan IIICEOSell2,664$8.11$21,605.0480,723View SEC Filing Icon  
3/11/2024Jay MatushakCFOSell193$8.11$1,565.2310,514View SEC Filing Icon  
3/11/2024Jeffery Michael CraigInsiderSell117$8.11$948.874,164View SEC Filing Icon  
3/11/2024Jeffrey J SchermanCAOSell76$8.11$616.364,318View SEC Filing Icon  
3/11/2024Tomas OrozcoEVPSell60$8.11$486.606,161View SEC Filing Icon  
3/7/2024George Lawrence Mikan IIICEOSell7,886$9.88$77,913.6888,483View SEC Filing Icon  
3/7/2024Jay MatushakCFOSell570$9.88$5,631.6011,076View SEC Filing Icon  
3/7/2024Jeffery Michael CraigInsiderSell347$9.88$3,428.364,505View SEC Filing Icon  
3/7/2024Jeffrey J SchermanCAOSell224$9.88$2,213.124,539View SEC Filing Icon  
3/7/2024Tomas OrozcoEVPSell179$9.88$1,768.526,336View SEC Filing Icon  
See Full Table
Urgent Nvidia Warning
From Altimetry   |   Ad
Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
Click here to access…

SEC Filings (Institutional Ownership Changes) for NeueHealth (NYSE:NEUE)

63.88% of NeueHealth stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

NeueHealth logo
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Read More on NeueHealth

Today's Range

Now: $6.07
Low: $6.04
High: $6.31

50 Day Range

MA: $6.88
Low: $5.82
High: $10.10

52 Week Range

Now: $6.07
Low: $4.94
High: $37.20

Volume

4,706 shs

Average Volume

30,051 shs

Market Capitalization

$49.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.77

Who are the company insiders with the largest holdings of NeueHealth?

NeueHealth's top insider investors include:
  1. George Lawrence Mikan III (CEO)
  2. Jay Matushak (CFO)
  3. Tomas Orozco (EVP)
  4. Jeffrey J Scherman (CAO)
  5. Jeffery Michael Craig (Insider)
Learn More about top insider investors at NeueHealth.
Biden replacement revealed?
From Paradigm Press   |   Ad
A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.
See his shocking evidence in this new report